Composition:

Each film coated tablet contains: 
Erlotinib Hydrochloride
equivalent to Erlotinib 150mg

Excipients q.s.
Colour: Titanium dioxide
Red Oxide of Iron
Yellow Oxide of Iron

Each film coated tablet contains: 
Erlotinib Hydrochloride 100mg
equivalent to Erlotinib q.s.

Excipients 
Colour: Titanium dioxide
Red Oxide of Iron
Yellow Oxide of Iron

INDICATIONS AND USAGE


Non-Small Cell Lung Cancer:Erlotinib is indicated for the treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer after failure of at least one prior chemotherapy regimen.

Pancreatic CancerErlotinib in combination with Gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic Pancreatic Cancer.